European innovation-intensive industries including pharmaceuticals and technology face growing uncertainty as trade tensions threaten research investment and long-term competitive positioning. These sectors require stable regulatory environments and predictable market access to justify substantial development investments.
The pharmaceutical industry’s inclusion in Trump’s “crosshairs” creates particular concern given the sector’s strategic importance for European technological leadership and economic competitiveness. Uncertainty about future market access could reduce research investment and innovation capacity.
Technology sector disputes over regulation and market access illustrate how modern trade conflicts extend beyond traditional manufacturing to encompass knowledge-intensive industries central to future economic growth. These disputes may have lasting effects on innovation ecosystems.
The innovation sector challenges demonstrate how trade wars can damage long-term competitive capacity even when immediate tariff impacts appear manageable. Research-intensive industries require predictable environments that sustained trade conflicts cannot provide.
